Sickle cell disease corrected in human models using stem cell-based gene therapy ( own cure other than stem cell transplan...)

Sickle cell disease corrected in human models using stem cell-based gene therapy

own cure other than stem cell transplantation.

To treat SCD, Sloan-Kettering scientists devised a novel engineering strategy combining RNA interference with globin gene transfer by creating a therapeutic transgene, consisting of the gamma-globin gene and small interfering RNA specific for beta S-globin, the globin mutant chain that causes sickle cell disease.

"An innovative and sophisticated approach was needed to genetically engineer hematopoietic stem cells using a practical and clinically applicable process. The transferred gene must not disrupt the cells' normal functions," explained Isabelle Riviere, PhD, Co-Director of the Gene Transfer and Somatic Cell Engineering Facility and a study co-author.

The new gene had two functions -- produce normal hemoglobin and suppress the generation of sickle shaped hemoglobin S. The therapeutic gene was engineered into a lentiviral vector and introduced into hematopoietic stem cells. After the cells received the treatment, they made normal hemoglobin.

"This proved our hypothesis that you can simultaneously add one function and delete another in the same cell and obtain synergistic genetic modifications within a single cell," said Selda Samakoglu, PhD, a member of Dr. Sadelain's laboratory and the study's first author. "In this case, we used the technique to correct sickle cell disease, but it should be broadly applicable to use therapeutically in stem cells or malignant cells."

Source:Memorial Sloan-Kettering Cancer Center

Page: 1 2
Related biology news :

1. Discovery Promises Simpler Therapy for Sickle Cell Disease
2. Sickle cell and protection against malaria
3. Neuronal traffic jam marks early Alzheimers disease
4. Scientists detect probable genetic cause of some Parkinsons disease cases
5. Ecological destruction fuels emerging diseases
6. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
7. U of M researcher examines newly emerging deadly disease
8. Marburg virus disease in Angola - update
9. Molecular machine may lead to new drugs to combat human diseases
10. Female sex hormones play a vital role in defense against sexually transmitted diseases
11. A bacterial genome reveals new targets to combat infectious disease

Post Your Comments:

(Date:12/15/2009)... WI, December 15, 2009 Economics, environmental impacts, ... factors that influence the overall success of an ... on the system, forcing individuals and social groups ... order to survive. , Experiential learning theory ... result of firsthand experiences. Such lessons are especially ...

(Date:12/15/2009)... American researchers found the fossil remains of a whale, 4.5 ... for the first time, the results of the decay and ... cetacean, possibly a baleen whale from the Mysticeti group. , ... remains of a whale from the Lower Pliocene (five million ... is the first time that the results of the processes ...

(Date:12/15/2009)... HERNDON, Va., Dec. 15 The PTR Group, ... today announced that it has agreed to sponsor three ... US FIRST Robotics Competition ( http://usfirst.org ). ... high school teams in three different states. The ... in Rockwall, TX, and James Madison HS in Vienna, ...

Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2 Story of 4.5 million-year-old whale unveiled in Huelva 2 Story of 4.5 million-year-old whale unveiled in Huelva 3 The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2 ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 13440 1 ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 13440 2 LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 1 LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 2 Matrixx Initiatives Inc Sets Time for Discussion of First Quarter Fiscal 2010 Financial Results 53918 1 Matrixx Initiatives Inc Sets Time for Discussion of First Quarter Fiscal 2010 Financial Results 53918 2

[0] Experiential learning teaches change and adaptation [0] Story of 4.5 million-year-old whale unveiled in Huelva [0] The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams

... in the body, a virus such as HIV invades body ... membrane. Once inside the cell, the invading microbe's genetic material ... produce more copies of the virus, which then spill out ... assumed that once a virus begins fusing with a cell's ...

... in the impact of malaria is in prospect with a ... next year. Success in the trial would open the way ... debilitating and often fatal disease - over 500,000,000 people. ... is collaborating with the Papua New Guinea Institute of Medical ...

... San Francisco VA Medical Center (SFVAMC) and the University ... associated with lymphocytic bronchitis, which is thought to lead ... long-term failure of transplanted lungs. , The researchers hope ... and more accurate standard test for chronic lung rejection, ...

Other Biology News:Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 2 Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 3 Old drug, new tricks: Prospects for slashing the impact of malaria 2 Researchers identify genes associated with lung transplant rejection 2

Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development Old drug, new tricks: Prospects for slashing the impact of malaria Researchers identify genes associated with lung transplant rejection

(Date:12/15/2009)... Department of Energy (DOE) bio-energy research centers, has selected ... intellectual property. , ... ... Surety, LLC , the leading provider of data ... BioEnergy Institute (JBEI), one of three Department of Energy ...

(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, The Future ... to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The ... Future of Orphan Diseases Therapeutics - Market ...

(Date:12/15/2009)... Microscopy (AFM) have been developed and are opening up a ... The NeedleProbes’ cylindrical geometry enables researchers to measure surface ... all in a single force distance curve. , ... ... diameter NeedleProbes are enabling unique measurements at the ...

(Date:12/15/2009)... Dec. 15 The Center for ... Communications, is pleased to announce the full ... Accounting and Reporting Congress . The forum ... on March 16-17, 2010. ,, Over 1,500 ... have attended this premier event since its ...

[0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM [0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress

... Key milestones, - Strong R&D investments, especially in EHT Dx21 and ... - Recruitment of 311 samples achieved for EHT Dx21, ... - Expansion of the strategic collaboration with Allergan and extension, ... Appointment of a new Management Board, - New positioning of Genomic ...

... March 3 NeoGenomics, Inc. (OTC Bulletin Board: ... its fourth quarter and full year 2008 financial results on ... conference call to discuss their Q4 and full year 2008 ... Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 ...

... Leverage Respective Technology and Market Experience to Support ... Sparta Systems, Inc., the leading provider of ... the appointment of two software and life sciences ... Diane Carlson, vice president of marketing communications, and ...

ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009 Sparta Systems Bolsters Executive Leadership Team with Strategic Additions

Jak3 Antibody Ship: Hot Store: -20 C...

B3GALT2 Immunogen: B3GALT2 (NP_003774, 324 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...

WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...

... Rabbit polyclonal to ThPok ( Abpromise ... Synthetic peptide conjugated to KLH derived from ... ThPok. (Note: the amino acid sequence is ... ab23412 .) Entrez Gene ID: ...

Biology Products:

Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents Mouse Anti-Human WASF2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents Rabbit Anti-Human ThPok Polyclonal Antibody, Unconjugated from Abcam

( own cure other than stem cell transplan...)Sickle cell disease corrected in human models using stem cell-based gene therapy